Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists.

J W Clitherow; D I Scopes; M Skingle; C C Jordan; W Feniuk; I B Campbell; M C Carter; E W Collington; H E Connor; G A Higgins

doi:10.1021/jm00041a001

Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists.

Identifier:nobleid.org/w1/20260515/1BAEB6FB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/1BAEB6FB.svg?ark=w1%2F20260515%2F1BAEB6FB)](https://nobleid.org/work/w1/20260515/1BAEB6FB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists.

Identifier:nobleid.org/w1/20260515/1BAEB6FB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/1BAEB6FB.svg?ark=w1%2F20260515%2F1BAEB6FB)](https://nobleid.org/work/w1/20260515/1BAEB6FB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work